Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSION PROTEIN COMPRISING ANNEXIN A2 BINDING PROTEIN, P53 PROTEIN, AND P18 PROTEIN, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING CANCER
Document Type and Number:
WIPO Patent Application WO/2015/009082
Kind Code:
A1
Abstract:
The present invention relates to a fusion protein comprising annexin A2 binding protein, p53 protein, and p18 protein, and a composition containing the same for preventing or treating cancer.

Inventors:
KIM JUNG MIN (KR)
LEE JAE IL (KR)
LEE JUNG MIN (KR)
Application Number:
PCT/KR2014/006510
Publication Date:
January 22, 2015
Filing Date:
July 17, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SAMSUNG ELECTRONICS CO LTD (KR)
International Classes:
C07K19/00; A61K38/16; A61P35/00; C12N15/62
Foreign References:
KR20110062997A2011-06-10
KR20090029868A2009-03-24
JP4594575B22010-12-08
Other References:
HUANG ET AL.: "Involvement of Annexin A2 in p53 induced apoptosis in lung cancer", MOLECULAR AND CELLULAR BIOCHEMISTRY, vol. 309, 2008, pages 117 - 123, XP019578330
WANG ET AL.: "Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 287, no. 39, 2012, pages 32512 - 32524
Attorney, Agent or Firm:
PANKOREA PATENT AND LAW FIRM (KR)
팬코리아특허법인 (KR)
Download PDF: